Natarajan Aravindan

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Journal of cancer metastasis and treatment

Cell biology and toxicology

World journal of pediatrics : WJP

BMC cancer

Andhra University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Andhra University Feb 11 1996 - Dec 29 1999

India

PHD :: Zoology

Pondicherry University

India

MSC :: KM Center for Post Graduate Studies

Pondicherry University

India

BSC :: Tagore Arts College

Publications

Dinesh Babu Somasundaram, Andrew Maher, Sheeja Aravindan, Zhongxin Yu, Brian M Besch, Natarajan Aravindan
Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma. World journal of pediatrics : WJP (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Natarajan Aravindan, Mohan Natarajan, Dinesh Babu Somasundaram, Sheeja Aravindan
Chemoprevention of neuroblastoma: progress and promise beyond uncertainties. Journal of cancer metastasis and treatment 9 (2023)
Dinesh Babu Somasundaram, Sheeja Aravindan, Nandita Gupta, Zhongxin Yu, Ashley Baker, Natarajan Aravindan
ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma. World journal of pediatrics : WJP 18 (4) (2022)
Drishti Jain, Dinesh Babu Somasundaram, Sheeja Aravindan, Zhongxin Yu, Ashley A Baker, Azadeh Esmaeili, Natarajan Aravindan
Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance. Cell biology and toxicology (2021)
Natarajan Aravindan, Dinesh Babu Somasundaram, Terence S Herman, Sheeja Aravindan
Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs. Cell biology and toxicology 37 (3) (2020)
Karthikeyan Rajamani, Somasundaram S Thirugnanasambandan, Chidambaram Natesan, Sethupathy Subramaniam, Balasubramanian Thangavel, Natarajan Aravindan
Squalene deters drivers of RCC disease progression beyond VHL status. Cell biology and toxicology 37 (4) (2020)
Natarajan Aravindan, Terence S Herman, Sheeja Aravindan
Emerging therapeutic targets for neuroblastoma. Expert opinion on therapeutic targets 24 (9) (2020)
Sheeja Aravindan, Dinesh Babu Somasundaram, Somasundaram T Somasundaram, Mohan Natarajan, Terence S Herman, Natarajan Aravindan
Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols. Molecular and cellular biochemistry 460 (1-2) (2019)
Dinesh Babu Somasundaram, Sheeja Aravindan, Zhongxin Yu, Muralidharan Jayaraman, Ngoc T B Tran, Shibo Li, Terence S Herman, Natarajan Aravindan
Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples. BMC cancer 19 (1) (2019)

Natarajan Aravindan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Natarajan Aravindan